Transforming growth factor-b (TGF-b) signaling in naive T cells induces expression of the transcription factor Foxp3, a 'master' regulator of regulatory T cells (T reg cells). However, the molecular mechanisms leading to Foxp3 induction remain unclear. Here we show that Itch -/-T cells were resistant to TGF-b treatment and had less Foxp3 expression. The E3 ubiquitin ligase Itch associated with and promoted conjugation of ubiquitin to the transcription factor TIEG1. Itch cooperated with TIEG1 to induce Foxp3 expression, which was reversed by TIEG1 deficiency. Functionally, 'TGF-b-converted' T reg cells generated from TIEG1-deficient mice were unable to suppress airway inflammation in vivo. These results suggest TIEG and Itch contribute to a ubiquitin-dependent nonproteolytic pathway that regulates inducible Foxp3 expression and the control of allergic responses.
Transforming growth factor-b (TGF-b) signaling in naive T cells induces expression of the transcription factor Foxp3, a 'master' regulator of regulatory T cells (T reg cells). However, the molecular mechanisms leading to Foxp3 induction remain unclear. Here we show that Itch -/-T cells were resistant to TGF-b treatment and had less Foxp3 expression. The E3 ubiquitin ligase Itch associated with and promoted conjugation of ubiquitin to the transcription factor TIEG1. Itch cooperated with TIEG1 to induce Foxp3 expression, which was reversed by TIEG1 deficiency. Functionally, 'TGF-b-converted' T reg cells generated from TIEG1-deficient mice were unable to suppress airway inflammation in vivo. These results suggest TIEG and Itch contribute to a ubiquitin-dependent nonproteolytic pathway that regulates inducible Foxp3 expression and the control of allergic responses.
Allergic asthma is a chronic inflammatory disease of the airways characterized by higher serum immunoglobulin E (IgE) concentrations, airway hyper-responsiveness, excessive airway mucus production, lung eosinophilia and airway remodeling. Differentiation of CD4 + T cells into T helper type 2 (T H 2) cells renders them able to produce the cytokines interleukin 4 (IL-4), IL-5 and IL-13, which are critical for driving asthmatic pathogenesis 1,2 . The induction of T H 2 differentiation is regulated by many factors, including the properties of the antigens, the duration of stimulation, and genetic factors. In addition, the T H 2-mediated immune responses are counterbalanced by tolerogenic mechanisms that prevent excessive reactions. One of the tolerance mechanisms involves regulatory T cells (T reg cells), which limit allergic responses 3 . In mouse models of allergic asthma, repeated delivery of antigen to the respiratory tract results in inhibition of allergic responses to the same antigen after subsequent challenges 4 . Published studies have shown that repeated treatment with a low dose of antigen induces the generation of Foxp3 + CD4 + CD25 + T reg cell population, which accounts for the attenuation of T H 2-mediated airway inflammation 5, 6 . T reg cells represent a unique subpopulation of CD4 + T cells that suppress the effector function of other types of T cells and are critical regulators of the maintenance of self-tolerance 7, 8 . However, the mechanisms underlying the regulation of the generation of T reg cells during T H 2-mediated allergic responses remain unclear.
Transforming growth factor-b (TGF-b) is a multifunctional cytokine that has been linked to the regulation of immune responses 9 . Ablation of either TGF-b or its receptor results in excessive T cell responses and severe autoimmunity [10] [11] [12] [13] . TGF-b is important in the conversion of naive CD4 + T cells into Foxp3 + T reg cells in vitro and the maintenance of T reg cells in vivo 11, [14] [15] [16] . It has been shown that TGF-b, in cooperation with IL-6, promotes the development of IL-17-producing T helper cells (T H -17 cells), a T helper cell subset involved in autoimmune and inflammatory responses 17 . At present, the intracellular signaling pathways that link TGF-b signaling to diverse or even opposing T cell functions remain mostly unclear.
Itch is an E3 ubiquitin ligase originally identified by genetic analysis of a mutant mouse with aberrant immunological phenotypes and constant scratching of the skin 18 . Functional analysis of Itch -/-T cells showed that they are biased toward the differentiation of T H 2 cells with augmented T H 2 cytokine production and serum IgE titers 19 . One mechanism by which Itch regulates T cell responses is the induction of T cell anergy in which T cells become unresponsive after restimulation 20 . In a mouse model of T cell tolerance, systemic injection of a high dose of soluble antigen failed to block the development of airway inflammation in Itch -/-mice, which indicates that Itch is important in the tolerogenic process of T H 2 cells 21 . However, detailed mechanisms underlying Itch-mediated protein ubiquitination in immune tolerance and allergic responses remain to be investigated.
To address those issues, we investigated whether Itch is involved in Foxp3 expression and the generation of T reg cells. Here we provide both genetic and biochemical evidence that Itch is critically involved in the generation of T reg cells by targeting ubiquitination of the transcription factor TIEG1 (TGF-b-inducible early gene 1 product) and promoting its transcriptional activation. This nonproteolytic pathway is important in the regulation of T H 2-mediated allergic responses. Supplementary Fig. 1a online) . Similarly, CD4 + CD25 + T reg cells from both types of mice had similar expression of other T reg cell markers such as GITR and CTLA-4 ( Supplementary Fig. 1b) . These results suggest that Itch is not involved in the development of naturally occurring CD25 + CD4 + T reg cells.
RESULTS

Itch
Next we determined by in vitro coculture assay whether there was functional alteration of T reg cells due to Itch ablation. We labeled CD4 + CD25 -T cells sorted from both wild-type and Itch -/-mice with the cytosolic dye CFSE and incubated them with flow cytometrysorted CD4 + CD25 + T reg cells from those mice. We stimulated the cells with antibody to CD3 (anti-CD3) in the presence of irradiated antigen-presenting cells and assessed cell division by flow cytometry of CFSE dilution. T reg cells from wild-type mice and Itch -/-mice had a similar extent of inhibition of the division of CD4 + CD25 -T cells from wild-type mice (Fig. 1a) . However, T reg cells from either wild-type or Itch -/-mice failed to inhibit the division of CD4 + CD25 -T cells from Itch -/-mice. To further confirm and quantify that finding, we analyzed thymidine incorporation in a similar coculture assay. As in the CFSE dilution experiment, Itch -/-CD4 + CD25 -T cells were not responsive to the suppressive effect of T reg cells from either wild-type or Itch -/-mice (Fig. 1b) . These results suggest that Itch -/-responder T cells are not susceptible to T reg cell-mediated inhibition.
Published studies have documented that TGF-b is a critical cytokine in T reg cell-mediated suppression of T cells 9 . To understand the mechanisms underlying the resistance of CD4 + CD25 -Itch -/-T cells to treatment with T reg cells, we first examined the effect of TGF-b on the inhibition of T cell proliferation. We stimulated CD4 + CD25 -T cells from wild-type and Itch -/-mice with anti-CD3 plus anti-CD28 in the presence of various amounts of TGF-b. As expected, wild-type T cells showed less proliferation in the presence of increasing amounts of TGF-b (Fig. 1c) . However, Itch -/-T cells were much less responsive to TGF-b treatment, even with a higher concentration of TGF-b.
Itch affects the TGF-b-mediated conversion of T reg cells
It is known that TGF-b can convert CD4 + CD25 -T cells into Foxp3 + T reg cells in vitro 14, 15 . To further understand the effect of Itch deficiency on TGF-b signaling in T cells, we examined the Foxp3 expression in both wild-type and Itch -/-CD4 + CD25 -T cells after incubation with TGF-b. Treatment with TGF-b resulted in upregulation of Foxp3 transcription and Foxp3 protein expression in wild-type T cells (Fig. 2a,b) . Itch deficiency resulted in much less Foxp3 expression. We next assessed the functional properties of the in vitro-converted T reg cells by coculture assay. In vitro-converted T reg cells from wild-type mice showed suppressive activity toward CD4 + CD25 -T cells, whereas TGF-b-treated Itch -/-T cells were much less inhibitory (Fig. 2c) . We then reconstituted Foxp3 expression by retroviral transduction of wild-type and Itch -/-T cells and found that the defective inhibitory function of Itch -/-T cells was compensated by Foxp3 expression ( Supplementary Fig. 2a,b online) .
Because Itch -/-T cells are biased toward T H 2 cell differentiation, we examined the involvement of IL-4 in Foxp3 expression. Intracellular staining of individual T cells showed that the lower Foxp3 expression and higher IL-4 production were independent events and that neutralizing IL-4 in the cell culture did not affect Foxp3 expression (Fig. 2d,e) . These results collectively suggest that loss of Itch alters TGF-b signaling in T cells and affects TGF-b-induced Foxp3 expression, even though Itch does not affect the development of naturally occurring CD4 + CD25 + T reg cells.
TIEG1 as a target of Itch
To understand the mechanisms underlying the hyporesponsiveness of Itch -/-T cells to TGF-b treatment, we analyzed intracellular signaling pathways in wild-type and Itch -/-T cells. First we assessed the phosphorylation status of signal transducer Smad2 proteins after TGF-b stimulation. In repeated experiments, we found that Itch deficiency did not overtly affect Smad2 phosphorylation (Fig. 3a) . We also measured the abundance of Smad2, Smad4 and Smad7 protein and noted little difference in wild-type versus Itch -/-T cells for up to 8 h of stimulation (data not shown). These results suggest that proximal 'downstream' signaling of the TGF-b receptor is relatively normal in Itch -/-T cells.
We next sought signaling molecules further 'downstream' that might act as target proteins for Itch. One putative target was TIEG1, which is rapidly induced after TGF-b stimulation and functionally mimics TGF-b-mediated transcriptional events in transient transfection systems 22 . Structurally, TIEG1 contains many proline-rich sequences that may be recognized by Itch 'WW' domains (which have two highly conserved tryptophan residues) and zincfinger DNA-binding domains that mediate gene transcription. To test our hypothesis, we generated a fusion protein of glutathione S-transferase and TIEG1 (GST-TIEG1) and did a precipitation assay with lysates of primary mouse T cells. GST-TIEG1 precipitated Itch, but GST alone did not (Fig. 3b) , and this association was not dependent on stimulation with TGF-b (Fig. 3c) . The interaction seemed to be mediated by Itch WW domains, as GST-WW precipitated TIEG1 from the mouse T cell lysates (Fig. 3d) . Finally, we determined by coimmunoprecipitation assay whether this interaction occurred endogenously in T cells. Itch was 'coimmunopurified' with a TIEG1-specific antibody and TIEG1 was coprecipitated by anti-Itch (Fig. 3e) . These results suggest that Itch forms a complex with TIEG1 in T cells. We next determined whether Itch acts as an E3 ubiquitin ligase for TIEG1. For this, we expressed Myc-tagged TIEG1 together with wildtype Itch or a ligase-deficient 'Itch-CA' mutant 19 , in which the activesite cysteine residue at position 822 is substituted with alanine, in human embryonic kidney 293T cells, along with hemagglutinin-tagged ubiquitin. Wild-type Itch induced the conjugation of ubiquitin to TIEG1, as shown by the formation of slowly migrating high-molecularweight species (Fig. 3f) . However, loss of the E3 ligase activity of Itch abrogated the conjugation of ubiquitin to TIEG1. We detected a lowmolecular-weight band in cells expressing Itch; this represented a single ubiquitin conjugated to TIEG1. Coexpression of an active form of the TGF-b receptor enhanced Itch-promoted conjugation of ubiquitin to TIEG1 in both the mono-and poly-ubiquitinated forms (Fig. 3g) . We detected the monoubiquitinated form in the nuclear fraction of cells expressing Itch (Fig. 3h) . These results indicate that Itch functions as an E3 ligase for TIEG1.
Involvement of TIEG1 in Foxp3 expression
To investigate the involvement of TIEG1 in Foxp3 expression, we first tested whether TIEG1 affected transactivation of the Foxp3 promoter in a luciferase reporter assay. Transient expression of TIEG1 resulted in greater Foxp3-driven luciferase activity after stimulation with TGF-b (Fig. 4a) . Notably, coexpression of Itch plus TIEG1 greatly augmented transactivation of the Foxp3 promoter, whereas such enhancement was abolished by coexpression of the ligase-deficient Itch-CA mutant plus TIEG1. To determine whether TIEG1 directly binds to the Foxp3 promoter, we did an electrophoretic mobility-shift assay (EMSA) with a probe corresponding to the putative binding sequences for the transcription factor Sp1 in the Foxp3 promoter. The mobility of the radiolabeled probe was retarded by the formation of complexes with cellular proteins in TGF-b stimulated T cells, and these were recognized by anti-TIEG1 (Fig. 4b) . In addition, DNA-binding ability was almost completely abolished in TGF-b-stimulated Itch -/-T cells (Fig. 4c) . Furthermore, anti-TIEG1 precipitated Foxp3 promoter region fragments in TGF-b-stimulated wild-type T cells but not in Itch -/-T cells (Fig. 4d) , which supported the idea that Itch is an essential regulator of TIEG1-mediated transactivation. We further tested the importance of TIEG1 ubiquitination in 293T cells transfected with hemagglutinin-tagged ubiquitin and TIEG1 plus Itch plasmids. Antibody to hemagglutinin (ubiquitin), which in principle precipitates ubiquitin-labeled TIEG1, also caused 'supershifting' of the TIEG1-DNA probe complex (Fig. 4e) . The defects in Foxp3 expression and binding of TIEG1 to Foxp3 promoter in Itch -/-T cells were 'rescued' by reconstitution with wild-type Itch but not with the ligase-deficient Itch-CA mutant (Fig. 4f,g ).
Because Itch promoted both monoubiquitination and polyubiquitination of TIEG1, we tested whether Itch affects the stability of TIEG1. We stimulated wild-type and Itch -/-T cells with TGF-b and induced TIEG1 expression 2 h later and found that the amount of TIEG1 was similar in these cells over a period of 8 h of incubation (Fig. 5a ). To identify a direct function for TIEG1 in Foxp3 expression, we expressed TIEG1 in mouse CD4 + T cells by retroviral transduction and measured Foxp3 protein expression. TIEG1 expression resulted in Foxp3 expression in wild-type CD4 + T cells (Fig. 5b) . However, Itch -/-T cells had much less induction of Foxp3. We also quantified Foxp3 by immunoblot analysis with a Foxp3-specific antibody. Itch -/-T cells transduced with TIEG1 had less Foxp3 expression in unstimulated or TGF-b-stimulated conditions (Fig. 5c) . These results show that TIEG1 is a positive regulator of Foxp3 expression and that its activity is dependent on Itch-mediated ubiquitination.
TIEG1 ablation affects Foxp3 expression and T reg cell function
To further elucidate the involvement of TIEG1 in Foxp3 expression, we compared the responsiveness of wild-type and TIEG1-deficient T cells to treatment with TGF-b. Like Itch -/-T cells, TIEG1-deficient T cells were resistant to TGF-b-induced inhibition of proliferation (Fig. 6a) . The development of naturally occurring T reg cells was slightly impaired in TIEG1-deficient mice ( Supplementary Fig. 3 online). The difference was much more obvious for TGF-b-induced Foxp3 expression in the in vitro culture system, with TIEG1-deficient T cells having much less Foxp3 expression after TGF-b stimulation (Fig. 6b) . We also examined the biological function of 'TGF-bconverted' T reg cells from both wild-type and TIEG1-deficient mice in the coculture assay and found that TGF-b-treated TIEG1-deficient CD4 + T cells had a much less inhibitory effect on the responder T cells than did TGF-b-treated wild-type CD4 + T cells (Fig. 6c) . We also tested the involvement of Jun proteins, another target of Itch 19 , in Foxp3 expression by 'knockdown' with small interfering RNA and found that lower expression of JunB and c-Jun did not affect Foxp3 expression ( Supplementary Fig. 4 online) . In addition, TIEG1 did not associate with Cbl-b ( Supplementary Fig. 5 online) , another E3 ligase involved in Foxp3 expression 23 . These results provide genetic evidence that TIEG1 is involved in TGF-b-induced Foxp3 expression and the suppressive function of adaptive T reg cells. We then investigated whether reconstitution of TIEG1 in TIEG1-deficient T cells 'rescued' the defect in Foxp3 expression.
Re-expression of TIEG1 restored Foxp3 expression in TIEG1-deficient cells to expression similar to that of wild-type T cells after TGF-b stimulation (Fig. 7a) . Further functional studies showed that like Itch -/-T cells, TIEG1-deficient CD4 + CD25 -responder T cells were also resistant to the inhibitory effect of T reg cells (Fig. 7b) . In addition, reconstitution of TIEG1 in TIEG1-deficient T cells restored the susceptibility of these cells to inhibition by T reg cells. However, overexpression of TIEG1 in Itch -/-T cells did not affect their resistance to T reg cell-mediated inhibition.
TIEG1 regulates T reg cell-mediated airway inflammation
A published study has documented that TGF-b-converted T reg cells can suppress antigen-induced airway inflammation 14 . To further understand the functional implication of the Itch-regulated TIEG1-ubiquitination pathway in immune responses, we did adoptive transfer experiments by injecting mice with TGF-b-converted T cells from both wild-type and TIEG1-deficient mice, then inducing allergic responses with ovalbumin (OVA) antigen. Consistent with the previous study 14 , TGF-b-converted T reg cells from wild-type mice suppressed allergic responses, reflected by less lung inflammation (Fig. 8a) , less IL-4 production and eosinophil infiltration (Fig. 8b,c) , and lower serum IgE concentrations (Fig. 8d) . In contrast, TGF-b-treated T cells from TIEG1-deficient mice failed to inhibit the OVA antigen-induced allergic responses. However, adoptive transfer of TGF-b-treated, TIEG1-reconstituted T cells from either wild-type or TIEG1-deficient mice resulted in much less airway inflammation (Fig. 8) . In addition, Itch -/-mice showed similar resistance to tolerance induction and excessive airway inflammation after intranasal antigen exposure ( Supplementary Figs. 6-10 online) . These results indicate that TIEG1 is critical to T reg cell-regulated allergic responses. expression. Notably, unlike ubiquitination of other target proteins for Itch, such as JunB, conjugation of ubiquitin to TIEG1 enhanced its transcriptional activation of the Foxp3 promoter and Foxp3 expression. Involvement of TIEG1 in the function of T reg cells was further manifested by the defect of TGF-b-converted T reg cells from TIEG1-deficient mice in inhibiting T cell proliferation in vitro and antigen-induced airway inflammation in vivo. Thus, our study has demonstrated a ubiquitin-dependent, protein degradationindependent transcriptional activation pathway that is important in T reg cell function and T reg cell-regulated allergic responses.
DISCUSSION
TIEG1 is a member of the Sp1-like family of zinc-finger transcription factors; it contains transcriptional regulatory domains at its amino terminus and three DNA-binding zinc-finger motifs 23 . TIEG1 is rapidly upregulated after treatment of osteoblast cells with TGF-b, and ectopic expression of TIEG1 mimics TGF-b signaling in such cells 24 , whereas TIEG1 ablation results in defective osteoblast function 25 . Relevant to our study here, TIEG1 is upregulated in both naturally occurring T reg cells 26 and in vitro-stimulated T cells. We found that transient expression of TIEG1 resulted in upregulation of Foxp3 promoter-driven luciferase activity and Foxp3 expression in primary T cells, a finding supported by the lower Foxp3 expression in TIEG1-deficient T cells. Sequence scanning of Foxp3 promoter has identified a GC-rich region as a potential binding region for the Sp1 family of transcription factors 27 . Indeed, using this particular GC-rich sequence as a probe, we have demonstrated by EMSA that it specifically bound to TIEG1. Notably, such binding was much lower in Itch -/-T cells after TGF-b stimulation. Our results suggest that Itchpromoted TIEG1 ubiquitination leads to transcriptional activation of Foxp3 by direct interaction of TIEG1 with the GC-rich sequences in the Foxp3 promoter. However, we cannot exclude the possibility that TIEG1 may exert its biological function by other mechanisms, such as by forming a complex with other transcription factors to induce Foxp3 expression. Examples of such transcription factor interactions include the association of NFAT with Foxp3 and of Runx1 with Foxp3; such interactions enhance the function of T reg cells 28, 29 .
Several proteins have been identified as substrates for Itch, with JunB and c-Jun being the most extensively studied 19, 30 . Conjugation of ubiquitin to JunB or c-Jun leads to their degradation after T cell stimulation, which is associated with the transcriptional regulation of T H 2 cytokines 19, 30 . To determine whether Itch-mediated Jun protein ubiquitination is involved in Foxp3 expression and T reg cell function, we did JunB and c-Jun small interfering RNA 'knockdown' experiments and found that lower expression of JunB and c-Jun in wild-type and Itch -/-T cells did not affect Foxp3 expression. Another E3 ligase, Cbl-b, has also been linked to Foxp3 expression 23 . It seems that Cbl-b does not directly associate with TIEG1, which suggests that Itch has a unique function in regulating TIEG1-mediated Foxp3 expression.
Like JunB, many transcription factors have been shown to undergo proteasome-dependent degradation, which is considered a counterbalancing mechanism for tight control of transcriptional responses 31 . Here we have provided evidence that conjugation of ubiquitin to TIEG1 did not lead to its degradation. Instead, ubiquitin modification promoted its transcriptional activation at the Foxp3 promoter. This phenomenon has been noted for other transcription factors such as VP16 and the human immunodeficiency virus-derived Tat proteins 32, 33 . One issue with those studies is that they used only artificial systems to test the function of ubiquitin in transcriptional activation. Although the exact mechanisms remain insufficiently clear to explain the ubiquitin-dependent control of transcription, our study has provided genetic evidence that such modification indeed positively regulates TIEG1-mediated Foxp3 expression.
We noted that Itch promoted conjugation of ubiquitin to TIEG1 in both mono-and polyubiquitinated forms. We hypothesize that the monoubiquitinated form is crucial for TIEG1 to exert transcriptional activity, an idea supported by the finding of monoubiquitinated TIEG1 in the nuclear fraction. In contrast, a published study has documented that the E3 ligase SIAH1 targets TIEG1 ubiquitination and subsequent degradation 34 . It may be possible that in physiological conditions, Itch mainly induces TIEG1 monoubiquitination without affecting its protein stability. Such an idea is also consistent with published studies showing that monoubiquitination enhances transactivation 35 . However, it may also be possible that monoubiquitination of TIEG1 modulates its translocation to the nucleus, an idea supported by the demonstration that monoubiquitination of PTEN facilitates its nuclear import and tumor suppression 36 . More notably, we found that Itch-promoted TIEG1 monoubiquitination was enhanced mainly by the coexpression of an activated TGF-b receptor, reinforcing the idea that 'monoconjugation' of ubiquitin to TIEG1 is critical for exertion of its transactivation of Foxp3 expression. The E3 ligase activity of Itch is tightly controlled by phosphorylation, particularly by the MEKK1 kinase-Jnk kinase signaling pathway 29, 37 . At present, we do not know whether the TGF-b receptor directly affects the E3 ligase activity of Itch or does so by activating 'downstream' kinases, including MEKK1. Nevertheless, our study paves the way for future exploration of the regulatory mechanisms underlying Itch-TIEG1-regulated Foxp3 expression in the context of TGF-b signaling.
A published study has shown that attenuated Foxp3 expression drives conventional CD4 + T cells into T H 2 type effector T cells, manifested by higher IL-4 production 38 , a phenomenon similar to that of Itch -/-T cells 19 . It may be possible that the lower Foxp3 expression in Itch -/-T cells after chronic antigen exposure facilitates T H 2 development, in addition to the direct involvement of Itch in modulating the transcription of genes encoding T H 2 cytokines, as reported before 19 . Indeed, chronic exposure to low-dose antigen failed to suppress airway inflammation in Itch -/-mice, accompanied by excessive T cell proliferation and less generation of CD4 + TGF-b + inducible T reg cells. In addition, TGF-b-converted T reg cells from Itch -/-mice were not effective in inhibiting airway inflammation. Therefore, a combinatory function of Itch in conventional T cells and in T reg cells tightly regulates the T H 2 differentiation, and loss of Itch results in excessive T H 2-mediated allergic responses. Thus, the identification of TIEG1 as target of Itch in regulating the generation and function of T reg cells may provide new insights into the search for additional therapeutic targets for immunological diseases.
METHODS
Mice. Itch -/-C57BL/6 mice, originally from the laboratory of N. Jenkins (National Cancer Institute), have been described 19 . Mouse genotypes were identified by PCR. TIEG1-deficient mice have been described 24 . Mice 8-12 week of age were used for experiments. The mice did not develop any apparent abnormality by least at 4 months of age in the animal facility. Animal experiments were done according to institutional guidelines approved by the Animal Care Committee of the La Jolla Institute for Allergy and Immunology.
Antibodies. Antibodies to Smad2 (sc-6200), Smad2-Smad3 (sc-6033), Smad4 (sc-7154), TGF-bR1 (sc-9048), Myc (sc-40), hemagglutinin (sc-57592), TIEG1 (sc-23159), actin (sc-1616) and Grb2 (sc-2550) were from Santa Cruz Biotechnology. Monoclonal antibody to Itch (611198) was from Transduction Laboratories. Anti-Xpress (R910-25) was from Invitrogen. Antibody to phosphorylated Smad2 (3108) was from Cell Signaling. Biotin-labeled anti-TGF-b (555052), phycoerythrin-labeled anti-CD4 (550630), allophycocyanin-labeled anti-CD25 (340938), phycoerythrin-labeled anti-GITR (558119) and phycoerythrin-labeled anti-CTLA-4 (555853) were from BD PharMingen. Anti-Foxp3 and phycoerythrin-labeled anti-Foxp3 (12-57773) were from eBioscience. Real time PCR. Total RNA from CD4 + CD25 -and CD4 + CD25 + cells isolated from Itch +/+ and Itch -/-mice was isolated with TRIzol, as described 21 . The abundance of mRNA was normalized to that of Hprt1 mRNA (encoding hypoxanthine guanine phosphoribosyl transferase). The following primers were used: Foxp3, 5¢-GGCCCTTCTCCAGGACAGA-3¢ (forward) and 5¢-GCTGAT CATGGCTGGGTTGT-3¢ (reverse); and Hprt1, 5¢-AGCCTAAGATGAGCG CAAGT-3¢ (forward) and 5¢-TTACTAGGCAGATGGCCACA-3¢ (reverse).
Plasmids and cell transfection. Mouse TIEG1 (Klf10) cDNA was cloned by PCR and was subcloned into pcDNA3 with a Myc tag or into retroviral vector pMAX-ires-GFP. Plasmids encoding Xpress-tagged Itch, the ligase-inactive mutant Itch-CA, hemagglutinin-tagged ubiquitin cDNA, Smad2, Smad7, TGF-b receptor type I and type II, and the constitutively active TGF-b receptor 1 have been described 39, 40 . The retroviral vectors pHSpG and pHSpG-Foxp3 and the Foxp3 promoter reporter pGL-Foxp3-luc have been described 41, 42 . The retroviral RNA-mediated interference 'knockdown' vector pSuper-Jun-B-CFP has been described 21 . The pSuper-c-Jun vector was inserted with a pCMV-YFP unit. For expression in 293T cells or human Jurkat T cells, cells were transfected with the appropriate amount of plasmid (usually 3-5 mg total) by electroporation (240V, 960 mF; Bio-Rad) or with the Fugene 6 transfection reagent (Roche).
Immunoprecipitation, immunoblot and precipitation assays. For detection of the interaction of Itch and TIEG1, CD4 + CD25 -cells were stimulated with TGF-b (5 ng/ml; R&D Systems) and then were lysed with Nonidet-P40 lysis buffer. Cell lysates were incubated for 2 h with 1 mg anti-Itch or anti-TIEG1. This was followed by incubation for 1 h at 4 1C with 30 ml protein G-Sepharose beads (Santa Cruz Biotechnology). Immunoprecipitates were washed five times with Nonidet-P40 lysis buffer, then were separated by 10% SDS-PAGE and electrotransferred onto nitrocellulose membranes. Membranes were hybridized to anti-Itch or anti-TIEG1, then were washed and visualized with enhanced chemiluminescence detection system (Amersham Pharmacia). Membranes were stripped by incubation for 45 min at 70 1C, with constant agitation, in a buffer of 62.5 mM Tris-HCl, pH 6.7, 100 mM 2-mercaptoethanol and 2% (wt/vol) SDS, then were washed and then reprobed with other antibodies.
GST-TIEG1 and GST-WW fusion proteins were expressed and purified as described 39 . For precipitation assays, 5 mg GST fusion protein was incubated for 2 h at 4 1C with cell lysates, followed by the addition for 1 h of 30 ml of glutathione-Sepharose beads (Amersham Pharmacia). Precipitates were washed five times with lysis buffer, then were separated by 10% SDS-PAGE and analyzed by immunoblot with anti-Itch or anti-TIEG1.
Retroviral transduction. CD4 + CD25 -cells isolated by flow cytometry sorting or with MACS beads (Miltenyi Biotech) were stimulated for 24 h with immobilized anti-CD3 (5 mg/ml) and anti-CD28 (1 mg/ml). Cells were infected by being mixed with green fluorescent protein (GFP)-tagged viral constructs supplemented with recombinant IL-2 (100 U/ml) and Polybrene (2.5 mg/ml), followed by centrifugation for 1 h at 700g. Cells were cultured for 4 h at 32 1C and then for 20 h at 37 1C. Infections were repeated 24 h after the initial infection. Cells were cultured for additional 3 d. GFP + cells were sorted by flow cytometry. Ubiquitination assay. For detection of ubiquitination of TIEG1, 293T cells were transfected with various constructs; then, 48 h later, 4 Â 10 6 cells were lysed in 100 ml denaturation buffer (1% (vol/vol) Nonidet-P40, 20 mM TrisHCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 5 mM sodium pyrophosphate, 5 mM sodium orthovanadate and 10 mg/ml each of aprotinin and leupeptin), to which SDS was added up to a concentration of 1%. Cell lysates were boiled for 10 min to disrupt nonspecific protein-protein interactions. Denatured samples were diluted in 900 ml lysis buffer, and insoluble materials were removed by centrifugation for 10 min at 4 1C and 15,000g. Cell lysates were then immunoprecipitated and blotted as described 19 .
EMSA. CD4 + T cells were left unstimulated or were stimulated with anti-CD3 plus anti-CD28 and recombinant TGF-b (5 ng/ml). Nuclear extracts were prepared by incubation of cells with buffer containing 10 mM HEPES, pH 7.9, 10 mM KCl, 2 mM MgCl 2 , 0.1 mM EDTA, 1 mM dithiothreitol and protease inhibitors. Cells were then 'spun down' for 5 min at 2,000g. Nuclear pellets were resuspended in extraction buffer containing 20 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.63 M NaCl, 25% (vol/vol) glycerol, 1% (vol/vol) Nonidet-P40, 0.5 mM dithiothreitol and protease inhibitors. Lysed nuclei were centrifuged for 30 min at 15,000g. For gel-shift assays, nuclear extracts were incubated with 32 P-labeled double-stranded oligonucleotides containing the GC-rich sequences in the promoter region of Foxp3 (5¢-AAAACTACAA GAACCCCCCCCCCACCCTGCAATTATCAGCAC-3¢). Binding reactions were done at 25 1C. For antibody supershift reactions, 1 mg anti-TIEG1, antihemagglutinin or control goat serum was added to the binding reaction mixture. Protein-DNA reaction mixtures were separated by 5% PAGE and were analyzed by autoradiography.
Chromatin immunoprecipitation assays. A chromatin-immunoprecipitation assay kit (Upstate-Millipore) was used according to the manufacturer's instructions for these assays. CD4 + CD25 -cells (2.5 Â 10 6 ) isolated from Itch +/+ and Itch -/-mice were stimulated with anti-CD3 plus anti-CD28 and TGF-b (5 ng/ml), then cells were fixed with 1% (vol/vol) formaldehyde and chromatin was fragmented by sonication. Sheared chromatin was precleared with salmon sperm DNA and protein A-agarose. Precleared chromatin was immunoprecipitated by overnight incubation at 4 1C with 2 mg control normal goat serum or anti-TIEG1 followed by incubation for 2 h with protein A-agarose. Precipitates were then 'defixed' and DNA was purified by phenolchloroform extraction. The immunoprecipitated Foxp3 promoter DNA
